- Trials with a EudraCT protocol (1,707)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (35)
1,707 result(s) found for: Chest.
Displaying page 1 of 86.
EudraCT Number: 2021-002288-24 | Sponsor Protocol Number: Ci-FCP001 | Start Date*: 2021-08-10 |
Sponsor Name:Amsterdam UMC | ||
Full Title: Effect of citalopram on chest pain in patients with functional chest pain | ||
Medical condition: Chest pain can be divided in cardiac or non-cardiac chest pain (NCCP). To establish the diagnosis NCCP, acute coronary disease has to be ruled out first. NCCP can be caused by functional chest pain... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2007-000969-37 | Sponsor Protocol Number: AN-SCD1121 | Start Date*: 2007-10-05 | |||||||||||
Sponsor Name:Anthera Pharmaceuticals Incorporated | |||||||||||||
Full Title: IMPACTS Trial: Investigation of the Modulation of Phospholipase in Acute Chest Syndrome (Dose Escalation Study: Varespladib Infusion [A-001] for the Prevention of Acute Chest Syndrome in At-Risk ... | |||||||||||||
Medical condition: Acute Chest Syndrome (ACS) in At-Risk patients with Sickle Cell Disease (SCD) and Vaso-occlusive Crisis (VOC) | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-002630-39 | Sponsor Protocol Number: 3tcAZ | Start Date*: 2011-10-25 |
Sponsor Name:Oslo University Hospital Rikshospitalet | ||
Full Title: MICROVASCULAR RESISTANCE IN WOMEN WITH CHEST PAIN AND NO OR MINIMAL CORONARY ARTERY DISEASE | ||
Medical condition: Investigation of otherwise healthy women with chest pain without significant stenoses in their epicardial coronary arteries. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NO (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2019-001202-14 | Sponsor Protocol Number: CiPA001 | Start Date*: 2019-06-05 |
Sponsor Name:Amsterdam UMC | ||
Full Title: CiPA Trial: Effect of Citalopram on chest pain in patients with achalasia | ||
Medical condition: Achalasia is a motility disorder of the esophagus. Disappearance of myenteric neurons in the esophageal wall leads to failure of relaxation of the lower esophageal sphincter (LES) and impaired peri... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2005-005226-31 | Sponsor Protocol Number: 1.1 | Start Date*: 2006-04-24 |
Sponsor Name:University of Oxford, Nuffield Department of Medicine | ||
Full Title: TIME 1 The First Therapeutic Intervention in Malignant Pleural Effusion Trial (TIME1) A 2 x 2 randomised factorial trial to assess whether non-steroidal anti-inflammatory analgesics and small bore... | ||
Medical condition: Malignant pleural effusion | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-006435-13 | Sponsor Protocol Number: 5065 | Start Date*: 2008-10-15 | ||||||||||||||||
Sponsor Name:University of Southampton | ||||||||||||||||||
Full Title: GRACE (Genomics to combat Resistance against Antibiotics in Community-acquired LRTI in Europe).Workpackage 10: Antibiotic Trial One | ||||||||||||||||||
Medical condition: Lower Respiratory Tract Infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: SI (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2006-001860-22 | Sponsor Protocol Number: CRT | Start Date*: 2007-06-04 |
Sponsor Name:Karl Andersen | ||
Full Title: CREATE. Cardiovascular Risk Evaluation and Attenuation of inflammation by early rosuvastatin TrEatment | ||
Medical condition: Patients with chest pain at rest or minimal physical activity of at least 20 minutes duration will be considered for inclusion in this study. To be eligible, patients have to be considered of low... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IS (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-007595-42 | Sponsor Protocol Number: | Start Date*: 2008-04-22 |
Sponsor Name:Cardiac Reserch Unit | ||
Full Title: Chest pain or other pain raising suspicion of an acute coronary syndrome. An evaluation of benzodiazipines and prehospital care. | ||
Medical condition: This study evaluates the possibility to improve symptoms prior to hospital admission among patients suffering from acute chest pain. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-002769-11 | Sponsor Protocol Number: Gabapentin02 | Start Date*: 2010-01-25 | ||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Department of Cardiothoracic and Vascular Surgery | ||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: THE EFFECT OF GABAPENTIN ON THORACIC EPIDURAL ANALGESIA FOLLOWING THORACOTOMY – A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL | ||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: The purpose of this trial is to investigate the effect of gabapentin on thoracic epidural analgesia following thoracotomy, including assessment of both analgesia, pain intensity, pain quality and w... | ||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001586-15 | Sponsor Protocol Number: 5065 | Start Date*: 2007-10-16 | ||||||||||||||||
Sponsor Name:University of Southampton | ||||||||||||||||||
Full Title: GRACE (Genomics to combat Resistance against Antibiotics in Community-acquired LRTI in Europe).Workpackage 10: Antibiotic Trial One | ||||||||||||||||||
Medical condition: Lower Respiratory Tract Infection | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: NL (Completed) GB (Completed) BE (Completed) SE (Completed) ES (Completed) IT (Completed) DE (Completed) FR (Completed) SK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2008-003596-46 | Sponsor Protocol Number: 942/08 | Start Date*: 2009-02-25 | ||||||||||||||||
Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI | ||||||||||||||||||
Full Title: Multicenter, not-for-profit clinical study, in a open, controlled, randomized fashion to compare tolerability, safety and efficacy of two different treatment strategies for non malignant, persisten... | ||||||||||||||||||
Medical condition: non neoplastic cronic pain | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001033-24 | Sponsor Protocol Number: 1234 | Start Date*: 2016-01-25 | |||||||||||
Sponsor Name:AOU CITTA' DELLA SALUTE E DELLA SCIENZA DI TORINO | |||||||||||||
Full Title: The management of post-operative pain nia patients undergoing cardiac surgery mini - invasive minithoracotomy : Randomized trial | |||||||||||||
Medical condition: The management of postoperative pain in patients undergoing cardiac surgery minimally invasive minithoracotomy : randomized | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005214-18 | Sponsor Protocol Number: T705-COVID-GCRI-Protocol-B | Start Date*: 2021-02-01 |
Sponsor Name:Vilnius University Hospital Santaros klinikos | ||
Full Title: An Investigation of the Efficacy and Safety of Favipiravir in COVID-19 Patients without Pneumonia − An open-label randomized controlled study | ||
Medical condition: COVID-19 Patients without Pneumonia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: LT (Prohibited by CA) | ||
Trial results: (No results available) |
EudraCT Number: 2006-000540-98 | Sponsor Protocol Number: 2005/495-31 | Start Date*: 2006-04-10 |
Sponsor Name:Karolinska University Hospital | ||
Full Title: Substudie Bröstmärta provocerad med iv bolus adenosin injektion i huvudstudie: Jämförelse mellan aktiv och passiv fysisk träning för behandling av persisterande angina pectoris - en randomiserad st... | ||
Medical condition: Refractory angina pectoris. Testing of sensitivity of chest pain provoked by iv bolus of adenosin before and after a training period with EECP (Enhanced External Counterpulsation) or physical exerc... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-002450-12 | Sponsor Protocol Number: LP0084-1194 | Start Date*: 2016-01-04 | |||||||||||
Sponsor Name:LEO Pharma A/S | |||||||||||||
Full Title: Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Face or Chest including 12-month follow-up Part 1: 3-day treatment period including an 8-week follow-up period Part 2:... | |||||||||||||
Medical condition: Actinic Keratosis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-002293-54 | Sponsor Protocol Number: Apex01version6 | Start Date*: 2007-11-29 |
Sponsor Name:University of Dundee | ||
Full Title: The APEX Trial: Effects of Allopurinol on Coronary and Peripheral Endothelial Function in Patients with Cardiac Syndrome X | ||
Medical condition: Patients with cardiac syndrome X (typical anginal-like chest pain and normal coronary arteriograms) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-002098-30 | Sponsor Protocol Number: | Start Date*: 2006-09-04 |
Sponsor Name:Erasmus Medical Centre Rotterdam | ||
Full Title: Efficacy of Inhaled RhDNase in Mechanically Ventilated Pediatric Patients with an Atelectasis | ||
Medical condition: Study population are: Children who develop an atelectasis during mechanical ventilation. An atelectasis is a collapsed part of the lung that is often caused by mucus plugs. | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2020-005128-12 | Sponsor Protocol Number: T705-COVID-GCRI-Protocol-A | Start Date*: 2021-02-01 |
Sponsor Name:Vilnius University Hospital Santaros klinikos | ||
Full Title: An Investigation of the Efficacy and Safety of Favipiravir in COVID-19 Patients with Mild Pneumonia − An open-label randomized controlled study | ||
Medical condition: COVID-19 Patients with Mild Pneumonia | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: LT (Prohibited by CA) | ||
Trial results: (No results available) |
EudraCT Number: 2013-003464-31 | Sponsor Protocol Number: BIOS-13-004 | Start Date*: 2014-02-21 |
Sponsor Name:Ethicon Inc | ||
Full Title: A Single-blinded, Randomized, Controlled, Comparative Phase III Study Evaluating the Safety and Effectiveness of EVARREST™ Fibrin Sealant Patch as an Adjunct to Hemostasis During Cardiovascular Sur... | ||
Medical condition: subjects undergoing major aortic surgery, including ascending, arch, or descending aorta replacement, requiring adjunctive support for hemostasis at the anastomotic suture line | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-002482-34 | Sponsor Protocol Number: GAM10-10 | Start Date*: 2020-05-21 |
Sponsor Name:Octapharma USA | ||
Full Title: Efficacy and safety of Octagam 10% therapy in COVID-19 patients with severe disease progression | ||
Medical condition: COVID-19 | ||
Disease: | ||
Population Age: Elderly | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
